TIPE2-Regulated ER-Phagy in Dendritic Cell Function Following Hemorrhagic Shock.

Area of Science:

• Immunology
• Cell Biology
• Autophagy Research

Background:

• Hemorrhagic shock (HS) causes immune dysfunction, characterized by systemic inflammation and multiple organ dysfunction, with dendritic cells (DCs) playing a key role.
• Endoplasmic reticulum autophagy (ER-phagy), a selective autophagy pathway, is crucial for DC function, but its role in HS-induced immune dysfunction is unclear.
• Tumor necrosis factor-α-induced protein-8-like 2 (TIPE2) is a known regulator of autophagy, suggesting its potential involvement in modulating DC ER-phagy during HS.

Purpose of the Study:

• To investigate the role of TIPE2 in regulating ER-phagy in DCs following hemorrhagic shock.
• To elucidate the impact of ER-phagy modulation by TIPE2 on DC function in the context of HS.

Main Methods:

• Analysis of ER-phagy markers (autophagosomes, ER-autophagosome colocalization, LC3-II/I ratio, SEC61B expression) in splenic DCs from wild-type (WT), TIPE2-/-, and TIPE2+/+ mice subjected to HS.
• In vitro stimulation of DCs with post-hemorrhagic shock mesenteric lymph (PHSML) to assess functional changes and ER-phagy.
• Investigation of TIPE2's interaction with the ER-phagy receptor tripartite motif 13 (TRIM13).

Main Results:

• Hemorrhagic shock significantly enhanced ER-phagy in DCs, evidenced by increased autophagosomes containing ER structures and greater ER-autophagosome colocalization.
• TIPE2 deficiency (TIPE2-/-) reduced ER-phagy and partially restored DC function, while TIPE2 overexpression (TIPE2+/+) intensified ER-phagy and DC dysfunction.
• TIPE2 was found to regulate the expression of the ER-phagy receptor TRIM13, suggesting a mechanism for its action.

Conclusions:

• ER-phagy is upregulated in DCs during hemorrhagic shock, contributing to immune dysfunction.
• TIPE2 plays a critical role in regulating ER-phagy in DCs following hemorrhagic shock, potentially via TRIM13.
• Targeting TIPE2-mediated ER-phagy presents a potential therapeutic strategy to improve DC function and mitigate immune dysfunction after hemorrhagic shock.